BIONDI, MARTA
BIONDI, MARTA
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
CARs are sharpening their weapons
2024 Pievani, A; Biondi, M; Tettamanti, S; Biondi, A; Dotti, G; Serafini, M
Fully equipped CARs to address tumor heterogeneity, enhance safety, and improve the functionality of cellular immunotherapies
2024 Alviano, A; Biondi, M; Grassenis, E; Biondi, A; Serafini, M; Tettamanti, S
Overexpression of CXCR4 receptor on CD33.CAR-CIK cells enhances the control of the Acute Myeloid Leukemia burden
2023 Biondi, M; Tettamanti, S; Galimberti, S; Cerina, B; Tomasoni, C; Dotti, G; Biondi, A; Pievani, A; Serafini, M
Selective homing of CAR-CIK cells to the bone marrow niche enhances control of the Acute Myeloid Leukemia burden
2023 Biondi, M; Tettamanti, S; Galimberti, S; Cerina, B; Tomasoni, C; Piazza, R; Donsante, S; Bido, S; Maria Perriello, V; Broccoli, V; Doni, A; Dazzi, F; Mantovani, A; Dotti, G; Biondi, A; Pievani, A; Serafini, M
CXCR4-MODIFIED CD33.CAR-CIK WITH ENHANCED BONE MARROW HOMING IN ACUTE MYELOID LEUKEMIA
2022 Biondi, M; Cerina, B; Tomasoni, C; Dotti, G; Tettamanti, S; Biondi, A; Pievani, A; Serafini, M
Enhancing AML CAR CIK therapeutic potency increasing the localization of engineered cells in the malignant niche and its selectivity by LSCs specific targeting
2022 Biondi, M
Improving Bone Marrow Homing and Persistence of CD33.CAR-CIK Cells By Overexpression of a Gain-of-Function Variant of CXCR4 to Increase Efficacy in Acute Myeloid Leukemia
2022 Biondi, M; Cerina, B; Tomasoni, C; Dotti, G; Tettamanti, S; Biondi, A; Pievani, A; Serafini, M
Ingegnerizzazione di cellule CD33.CAR-CIK con una variante gain-of-function del recettore CXCR4 per aumentarne migrazione e persistenza nella nicchia midollare
2022 Biondi, M; Cerina, B; Tomasoni, C; Dotti, G; Tettamanti, S; Biondi, A; Pievani, A; Serafini, M
Overexpression of CXCR4 Enhances the Efficacy of CAR-T Therapy for Acute Myeloid Leukemia
2022 Biondi, M; Galimberti, S; Cerina, B; Tomasoni, C; Dotti, G; Tettamanti, S; Biondi, A; Pievani, A; Serafini, M
Cellule CD33.CAR-CIK ingegnerizzate per co-esprimere il recettore CXCR4 al fine di aumentare la capacità di migrazione all’interno della nicchia midollare nella leucemia mieloide acuta
2021 Biondi, M; Cerina, B; Tomasoni, C; Dotti, G; Tettamanti, S; Biondi, A; Pievani, A; Serafini, M
Combining the expression of CD33.CAR and CXCR4 to augment CAR-CIKs homing to bone marrow niche and leukemic stem cell eradication in acute myeloid leukemia
2021 Biondi, M; Tomasoni, C; Dotti, G; Tettamanti, S; Biondi, A; Pievani, A; Serafini, M
Combining the Expression of CD33.CAR and CXCR4 to Increase CAR-CIK Cell Homing to Bone Marrow Niche and Leukemic Stem Cell Eradication in Acute Myeloid Leukemia
2021 Biondi, M; Cerina, B; Tomasoni, C; Dotti, G; Tettamanti, S; Biondi, A; Pievani, A; Serafini, M
Generation of CIK cells co-expressing CXCR4 and CD33.CAR with improved homing and antitumor activity for AML
2021 Biondi, M; Dotti, G; Biondi, A; Tettamanti, S; Pievani, A; Serafini, M
Location First: Targeting Acute Myeloid Leukemia Within Its Niche
2020 Pievani, A; Biondi, M; Tomasoni, C; Biondi, A; Serafini, M
Next-Generation Manufacturing Protocols Enriching TSCM CAR T Cells Can Overcome Disease-Specific T Cell Defects in Cancer Patients
2020 Arcangeli, S; Falcone, L; Camisa, B; De Girardi, F; Biondi, M; Giglio, F; Ciceri, F; Bonini, C; Bondanza, A; Casucci, M